Stockreport

Pieris Pharmaceuticals Announces Strategy to Maximize Partnered Milestone and Royalty Potential

Pieris Pharmaceuticals, Inc.  (PIRS) 
NASDAQ:AMEX Investor Relations: ir.pieris.com